

Cover Story
FreeGuest Editorial
As I look through just-published tables of age-adjusted cancer mortality, I recognize an unprecedented development:
By Alexandria Carolan
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets


Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- A new working group will conduct site visits and advise NCAB and NCI director on cancer center grants
- Michael Bishop, Nobel-winning cancer researcher, dies at 90
- At a jam-packed NCAB meeting, cancer vaccines and site visits take center stage
- Roy Herbst named director at Dartmouth Cancer Center
- In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt
















